Skip to main content

Advertisement

SpringerLink
Log in

Perfusion Scintigraphy for the Evaluation of Patients with Raynaud’s Phenomenon

  • Perspective
  • Published:
Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

Abstract

Raynaud’s phenomenon (RP) is a functional vascular disorder, which can be defined as transient vasospasm of the peripheral arteries and arterioles in the affected areas exposed to the cold or other stress. The diagnosis of RP is mainly based on symptoms. Perfusion scintigraphy, with or without cold stimulation, can be used to evaluate RP. Studies with perfusion scintigraphy for RP have shown that patients with RP showed lower finger-to-palm ratio than patients without RP. Responses after cold stimulation were also different in patients with RP. Not only decreased perfusion or blood pool after cold stimulation but also paradoxically increased perfusion can be shown in patients with RP. Some studies have shown that primary and secondary RP can be differentiated by perfusion scintigraphy. Correlation between duration of disease and findings on perfusion scintigraphy was reported. Perfusion scintigraphy can show differences before and after treatment as well. However, the protocols for perfusion scintigraphy for PR vary among studies. The standard protocol of perfusion scintigraphy for RP should be established.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Block JA, Sequeira W. Raynaud’s phenomenon. Lancet. 2001;357:2042–8.

    Article  CAS  Google Scholar 

  2. Goldman RD. Raynaud phenomenon in children. Can Fam Physician. 2019;65:264–5.

    PubMed  PubMed Central  Google Scholar 

  3. Lee JW, Jeong WS, Lee SM, Kim J. Comparison of the diagnostic performances of two protocols of hand perfusion scintigraphy for Raynaud’s phenomenon. Nucl Med Commun. 2012;33:1032–8.

    Article  Google Scholar 

  4. Maricq HR, Carpentier PH, Weinrich MC, Keil JE, Franco A, Drouet P, et al. Geographic variation in the prevalence of Raynaud’s phenomenon: Charleston, SC, USA, vs Tarentaise, Savoie, France. J Rheumatol. 1993;20:70–6.

    CAS  PubMed  Google Scholar 

  5. Purdie G, Harrison A, Purdie D. Prevalence of Raynaud’s phenomenon in the adult New Zealand population. N Z Med J. 2009;122:55–62.

    PubMed  Google Scholar 

  6. Pope JE. The diagnosis and treatment of Raynaud’s phenomenon: a practical approach. Drugs. 2007;67:517–25.

    Article  Google Scholar 

  7. Matucci-Cerinic C, Nagaraja V, Prignano F, Kahaleh B, Bellando-Randone S. The role of the dermatologist in Raynaud’s phenomenon: a clinical challenge. J Eur Acad Dermatol Venereol. 2018;32:1120–7.

    Article  CAS  Google Scholar 

  8. Hirschl M, Hirschl K, Lenz M, Katzenschlager R, Hutter HP, Kundi M. Transition from primary Raynaud’s phenomenon to secondary Raynaud’s phenomenon identified by diagnosis of an associated disease: results of ten years of prospective surveillance. Arthritis Rheum. 2006;54:1974–81.

    Article  Google Scholar 

  9. Isenberg DA, Black C. ABC of rheumatology. Raynaud’s phenomenon, scleroderma, and overlap syndromes. BMJ. 1995;310:795–8.

    Article  CAS  Google Scholar 

  10. Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud’s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum. 2008;58:3902–12.

    Article  Google Scholar 

  11. Cutolo M, Grassi W, Matucci CM. Raynaud’s phenomenon and the role of capillaroscopy. Arthritis Rheum. 2003;48:3023–30.

    Article  Google Scholar 

  12. Ingegnoli F, Gualtierotti R, Orenti A, Schioppo T, Marfia G, Campanella R, et al. Uniphasic blanching of the fingers, abnormal capillaroscopy in nonsymptomatic digits, and autoantibodies: expanding options to increase the level of suspicion of connective tissue diseases beyond the classification of Raynaud’s phenomenon. J Immunol Res. 2015;2015:371960.

    Article  Google Scholar 

  13. Secchi ME, Sulli A, Grollero M, Pizzorni C, Parodi M, Paolino S, et al. Role of videocapillaroscopy in early detection of transition from primary to secondary Raynaud’s phenomenon in systemic sclerosis. Reumatismo. 2008;60:102–7.

    CAS  PubMed  Google Scholar 

  14. Schmidt WA, Krause A, Schicke B, Wernicke D. Color Doppler ultrasonography of hand and finger arteries to differentiate primary from secondary forms of Raynaud’s phenomenon. J Rheumatol. 2008;35:1591–8.

    PubMed  Google Scholar 

  15. Rosato E, Borghese F, Pisarri S, Salsano F. Laser Doppler perfusion imaging is useful in the study of Raynaud’s phenomenon and improves the capillaroscopic diagnosis. J Rheumatol. 2009;36:2257–63.

    Article  Google Scholar 

  16. Cherkas LF, Carter L, Spector TD, Howell KJ, Black CM, MacGregor AJ. Use of thermographic criteria to identify Raynaud’s phenomenon in a population setting. J Rheumatol. 2003;30:720–2.

    PubMed  Google Scholar 

  17. Porta F, Gargani L, Kaloudi O, Schmidt WA, Picano E, Damjanov N, et al. The new frontiers of ultrasound in the complex world of vasculitides and scleroderma. Rheumatology (Oxford). 2012;51(Suppl 7):vii26–30.

    Article  Google Scholar 

  18. Merkel PA, Herlyn K, Martin RW, Anderson JJ, Mayes MD, Bell P, et al. Measuring disease activity and functional status in patients with scleroderma and Raynaud’s phenomenon. Arthritis Rheum. 2002;46:2410–20.

    Article  Google Scholar 

  19. Gladue H, Maranian P, Paulus HE, Khanna D. Evaluation of test characteristics for outcome measures used in Raynaud’s phenomenon clinical trials. Arthritis Care Res. 2013;65:630–6.

    Article  Google Scholar 

  20. Lim S-M, Chung J-K, Lee M-C, Choi S-J, Koh C-S, Kim S-J. Measurement of finger blood flow in Raynaud’s phenomenon by radionuclide angiography. Korean J Nucl Med. 1987;21:183–90.

    Google Scholar 

  21. Bang SH, Oh YS, Park HJ, Lee TK, Yang JS, Lee SM, et al. Evaluation of finger blood flow with Tc-99m MDP (methylene diphosphonate). Korean J Intern Med. 1992;7:94–101.

    Article  CAS  Google Scholar 

  22. Kwon SR, Lim MJ, Park SG, Hyun IY, Park W. Diagnosis of Raynaud’s phenomenon by (99m)Tc-hydroxymethylene diphosphonate digital blood flow scintigraphy after one-hand chilling. J Rheumatol. 2009;36:1663–70.

    Article  Google Scholar 

  23. Chong A, Ha JM, Song HC, Kim J, Choi SJ. Conversion to paradoxical finding on technetium-99m-labeled RBC scintigraphy after treatment for secondary Raynaud’s phenomenon. Nucl Med Mol Imaging. 2013;47:278–80.

    Article  Google Scholar 

  24. Pavlov-Dolijanovic S, Petrovic N, Vujasinovic Stupar N, Damjanov N, Radunovic G, Babic D, et al. Diagnosis of Raynaud’s phenomenon by (99m)Tc-pertechnetate hand perfusion scintigraphy: a pilot study. Rheumatol Int. 2016;36:1683–8.

    Article  CAS  Google Scholar 

  25. Lee KA, Chung HW, Lee SH, Kim HR. The use of hand perfusion scintigraphy to assess Raynaud’s phenomenon associated with hand-arm vibration syndrome. Clin Exp Rheumatol. 2017;35(Suppl 106):138–43.

    PubMed  Google Scholar 

  26. Csiki Z, Galuska L, Garai I, Szabo N, Varga J, Andras C, et al. Raynaud’s syndrome: comparison of late and early onset forms using hand perfusion scintigraphy. Rheumatol Int. 2006;26:1014–8.

    Article  CAS  Google Scholar 

  27. Csiki Z, Garai I, Varga J, Szucs G, Galajda Z, Andras C, et al. Microcirculation of the fingers in Raynaud’s syndrome: (99m)Tc-DTPA imaging. Nuklearmedizin. 2005;44:29–32.

    Article  CAS  Google Scholar 

  28. Galuska L, Garai I, Csiki Z, Varga J, Bodolay E, Bajnok L. The clinical usefulness of the fingers-to-palm ratio in different hand microcirculatory abnormalities. Nucl Med Commun. 2000;21:659–63.

    Article  CAS  Google Scholar 

  29. Kunnen JJ, Dahler HP, Doorenspleet JG, van Oene JC. Effects of intra-arterial ketanserin in Raynaud’s phenomenon assessed by 99MTc-pertechnetate scintigraphy. Eur J Clin Pharmacol. 1988;34:267–71.

    Article  CAS  Google Scholar 

  30. Sarikaya A, Ege T, Firat MF, Duran E. Assessment of digital ischaemia and evaluation of response to therapy by 99mTc sestamibi limb scintigraphy after local cooling of the hands in patients with vasospastic Raynaud’s syndrome. Nucl Med Commun. 2004;25:207–11.

    Article  Google Scholar 

  31. Porter JM, Snider RL, Bardana EJ, Rosch J, Eidemiller LR. The diagnosis and treatment of Raynaud’s phenomenon. Surgery. 1975;77:11–23.

    CAS  PubMed  Google Scholar 

  32. Davis EP, editor. The American Journal of the Medical Sciences. Vol. 108. Philadelphia: J.B. Lippincott; 1894.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nuclear Medicine, Chosun University Hospital, Chosun University School of Medicine, 365, Pilmun-daero, Dong-gu, Gwangju Metropolitan City, 61453, Republic of Korea

    Ari Chong

Authors
  1. Ari Chong
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ari Chong.

Ethics declarations

Conflict of Interest

Ari Chong declares that there is no conflict of interest with any financial organization regarding the material discussed in the manuscript.

Ethical Approval

This work does not contain any studies with human participants or animals performed by the author.

Informed Consent

Not applicable.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chong, A. Perfusion Scintigraphy for the Evaluation of Patients with Raynaud’s Phenomenon. Nucl Med Mol Imaging 54, 269–273 (2020). https://doi.org/10.1007/s13139-020-00671-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13139-020-00671-6

Keywords

Search

Navigation